TV-46000

· Teva Branded Pharmaceutical Products R&D, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TV-46000, covering 2021-12-09 to 2022-10-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia [Phase 3]